| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $94.6M | -31.8% |
| Cost of Revenue | $29.7M | -5.1% |
| R&D Expense | $20.0M | +62.1% |
| SG&A Expense | $21.2M | -15.6% |
| Operating Income | $23.7M | -66.1% |
| Pre-tax Income | $30.4M | -60.1% |
| Income Tax | $7.1M | -57.9% |
| Net Income | $23.3M | -60.7% |
| EPS (Basic) | $0.33 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $155.0M | -0.3% |
| Accounts Receivable | $3.3M | -84.6% |
| Inventory | $49.1M | -1.0% |
| Current Assets | $212.9M | -7.9% |
| Total Assets | $219.5M | -10.2% |
| Current Liabilities | $18.0M | -29.0% |
| Total Liabilities | $20.6M | -27.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $43.5M | -10.8% |
| Capital Expenditures | $355K | +736.3% |
| Investing Cash Flow | -$355K | -736.3% |
| Financing Cash Flow | -$43.6M | -0.2% |
| Free Cash Flow | $43.1M | -11.5% |
| -60.2% |
| EPS (Diluted) | $0.32 | -61.0% |
| Stockholders' Equity |
| $198.8M |
| -7.9% |